JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'nsc 87877'

Search results for: 'nsc 87877'

BA9100 NSC668036

Summary: NSC668036 is a structural domain inhibitor.
A3397 Erlotinib
4 Citation

Summary: EGFR tyrosine kinase inhibitor

insoluble in H2O; ≥19.65 mg/mL
A3514 JAK2 Inhibitor V, Z3

Summary: Jak2 tyrosine kinase inhibitor

Soluble in DMSO or ethanol
C3938 Misonidazole

Summary: nitroimidazole with radiosensitizing and antineoplastic properties

≤5 mg/mL
C4760 AG-82

Summary: inhibitor of EGFR kinase

≤20 mg/mL
C5539 Ciprofloxacin (hydrochloride)

Summary: fluoroquinolone antibiotic

insoluble in EtOH; ≥33.87 mg/mL
A3892 Triptonide

Target: dCTP Pyrophosphatases

Summary: dCTP Pyrophosphatase inhibitor

insoluble in H2O; insoluble in EtOH; ≥16.35 mg/mL
BA4561 Becatecarin

Summary: Becatcarin is a rebeccamycin analog with antitumor effects.
A8234 Erlotinib Hydrochloride
2 Citation

Summary: Selective EGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
A9076 Taurolithocholic Acid MaxSpec® Standard

Summary: Taurolithocholic acid is a quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications.

Soluble in DMSO